New performance of biosensor technology for Alzheimer's disease drugs: In vitro comparison of tacrine and 7-methoxytacrine

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 755-758

  Pohanka, Miroslav ^a,b   Kuca, Kamil ^a,b   Kassa, Jiri ^b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

7 MEOTA; 7 methoxytacrine; Alzheimer's disease; Biosensor; Cholinesterase; Cognex; Inhibition; Tacrine

Indexed keywords

7 METHOXYTACRINE; ACETYLCHOLINESTERASE; TACRINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BIOSENSOR; COGNITIVE DEFECT; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; NONHUMAN; PROCESS TECHNOLOGY; STRUCTURE ANALYSIS;

EID: 57149134942     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bajgar J, Fusek J, Patocka J, Hrdina V (1979). In vivo kinetics of blood cholinesterase inhibition by 9-amino-1,2,3,4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats. Physiol. Bohemoslov. 28: 31-34.
2. Bajgar J, Fusek J, Skopec F (1994). Changes of cholinesterases in the blood and some tissues following administration of Tacrin and its two derivatives to rats. Neurochem Int. 24: 555-558.
3. Bajgar J, Bisso M, Michalek H (1995). Differential inhibition of rat brain acetylcholinesterase molecular forms by 7-methoxytacrine in vitro. Toxicol Lett. 80: 109-114.
4. Branowska-Bik A, Bik W, Wolinska-Witort E, Martynska L, Chmielowsk M, Barcikowsk M, Baranowsk B (2008). Plasma beta amyloid and cytokine profile in women with Alzhiemer's disease. Neuroendocrinol Lett. 29: 75-79.
5. Dejmek L (1990). 7-MEOTA. Drugs of the Future. 15: 126-129.
6. Ezoulin MJM, Liu Z, Dutertre-Catellla H, Wu G, Dong CZ, Heymans SF, Ombetta JE, Rat P, Massicot F (2007). A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and proinflammatory mediators release in stumulated RAW 264.7 macrophage cells. Comparison with tacrine. Int Immunopharmacol. 7: 1685-1694.
7. Kopecek M, Cerna L, Sulak J, Raszka M, Bares M, Seifertova D (2007). Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuroendocrinol Lett. 28: 889-894.
8. Newhouse PA, Kelton M (2000). Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. Pharmaceutica Acta Helvetiae 74: 91-101.
9. Palenicek T, Hlinak Z, Bubenikova-Valesova V, Votava M, Horacek J (2007). An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Neuroendocinol Lett. 28: 781-788.
10. Pohanka M, Jun D, Kuca K (2007a). Amperometric biosensor for evaluation of competitive cholinesterase inhibition by the reactivator HI-6. Anal Lett. 40: 2351-2359.
11. Pohanka M, Pavlis O, Skladal P (2007b). Rapid characterization of monoclonal antibodies using the piezoelectric immunosensor. Sensors 7: 341-353.
12. Pohanka M, Jun D, Kuca K (2007c). Amperometric biosensors for real time assays of organophosphates. Sensors 8: 5303-5312.
13. Pohanka M, Jun D, Kalasz H, Kuca K (2008a). Cholinesterase biosensor construction - a review. Prot Pept Lett. 15: 795-798.
14. Pohanka M, Kuca K, Jun D (2008b). Sensor system based on acetylcholinesterase in homogenous phase for analysis of paraoxon. Anal Lett. 41: 2214-2223.
15. Pohanka M, Kuca K, Jun D (2008c). Aflatoxin assay using an amperometric sensor strip and acetylcholinesterase as recognition element. Sens Lett. 6: 450-453.
16. Stuerenburg HJ, Arlt S, Mueller-Thomsen T (2006). Free thyroxine, cognitive decline and depression in Alzheimer's disease. Neurondocrinol Lett. 27: 535-537.
17. Takatori YT, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A (2006). Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51: 474-486.
18. Tumiattit V, Bolognesi ML, Minarini A, Rosini M, Milelli A, Matera R, Melchiorre C (2008). Pogress in acetylcholinesterase inhibitors for Alzheimer's disease: an update. Expert Opin Ther Pat. 18: 387-401.
19. Vesela S, Ondruska V, Kuca K, Patocka J (2006). Freshwater microcrustacean Daphnia magna Straus as an early screen model to compare toxicity of acetylcholinesterase inhibitors. J Appl Biomed. 4: 105-110.
20. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delong MR (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebain. Science 215: 1237-1239.